IL114702A - Process for the production of biologically active transforming growth factor - Google Patents

Process for the production of biologically active transforming growth factor

Info

Publication number
IL114702A
IL114702A IL11470295A IL11470295A IL114702A IL 114702 A IL114702 A IL 114702A IL 11470295 A IL11470295 A IL 11470295A IL 11470295 A IL11470295 A IL 11470295A IL 114702 A IL114702 A IL 114702A
Authority
IL
Israel
Prior art keywords
growth factor
biologically active
transforming growth
production
active transforming
Prior art date
Application number
IL11470295A
Other languages
English (en)
Other versions
IL114702A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL114702A0 publication Critical patent/IL114702A0/xx
Publication of IL114702A publication Critical patent/IL114702A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11470295A 1994-07-25 1995-07-24 Process for the production of biologically active transforming growth factor IL114702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94810439 1994-07-25

Publications (2)

Publication Number Publication Date
IL114702A0 IL114702A0 (en) 1995-11-27
IL114702A true IL114702A (en) 2005-03-20

Family

ID=8218293

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11470295A IL114702A (en) 1994-07-25 1995-07-24 Process for the production of biologically active transforming growth factor

Country Status (19)

Country Link
US (1) US7057016B2 (da)
EP (1) EP0779896B1 (da)
JP (2) JPH11505404A (da)
KR (1) KR100394532B1 (da)
AT (1) ATE207934T1 (da)
AU (1) AU699879B2 (da)
CA (1) CA2194578A1 (da)
DE (1) DE69523611T2 (da)
DK (1) DK0779896T3 (da)
ES (1) ES2166402T3 (da)
FI (1) FI118385B (da)
HU (1) HU222829B1 (da)
IL (1) IL114702A (da)
NO (1) NO317730B1 (da)
NZ (1) NZ290374A (da)
PT (1) PT779896E (da)
TW (1) TW517059B (da)
WO (1) WO1996003433A1 (da)
ZA (1) ZA956139B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636739T2 (de) * 1995-12-21 2007-10-18 Ajinomoto Co., Inc. Verfahren zur rückfaltung von menschlichem activin a
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
US20030134292A1 (en) * 2001-10-30 2003-07-17 Farchaus Joseph W. Thermostable DNA polymerases and methods of making same
FR2871061B1 (fr) * 2004-06-04 2007-08-10 Coletica Sa Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
GB0604966D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US10647777B2 (en) * 2014-05-28 2020-05-12 Genzyme Corporation Methods of controlling the formation of disulfide bonds in protein solutions
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
NZ746109A (en) 2016-12-30 2022-12-23 Biogend Therapeutics Co Ltd Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
WO2023064747A1 (en) * 2021-10-11 2023-04-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Engineered tgf-beta monomers and methods of use
GB2616476A (en) * 2022-03-11 2023-09-13 Multus Biotechnology Ltd Recombinant transforming growth factor beta 3 in yeast

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0051985B2 (en) * 1980-11-07 1989-12-27 International Institute Of Cellular And Molecular Pathology (Icp) Immunoassay of proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (da) 1982-12-22 1984-10-02 Genentech Inc
DE3587022T2 (de) 1984-02-17 1993-06-17 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US4572798A (en) 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US4731440A (en) 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
IL78197A (en) 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
GB8508340D0 (en) 1985-03-29 1985-05-09 Creighton T E Production of protein
EP0208539A3 (en) 1985-07-11 1988-08-03 Repligen Corporation Folding disulfide-cross-linkable proteins
US5453363A (en) 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
NZ222168A (en) 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
PT86144B (pt) 1986-11-17 1990-08-31 Sandoz Sa Processo para a preparacao de uma proteina tendo actividade semelhante a factor g-tsf humano e de composicoes farmaceuticas que o contem
FI100106B (fi) 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
US4931548A (en) 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
IL86090A (en) 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
US5162507A (en) 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
ATE156491T1 (de) 1987-05-11 1997-08-15 Chiron Corp Prozess zur gewinnung von gereinigtem, oxidiertem, renaturiertem, rekombinantem interleukin-2 aus mikroorganismen
EP0293785A3 (en) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
US4985544A (en) 1987-08-04 1991-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for renaturing fish growth hormone
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein

Also Published As

Publication number Publication date
JPH11505404A (ja) 1999-05-21
HU222829B1 (hu) 2003-11-28
US20020115834A1 (en) 2002-08-22
ES2166402T3 (es) 2002-04-16
TW517059B (en) 2003-01-11
NO317730B1 (no) 2004-12-13
HUT76667A (en) 1997-10-28
US7057016B2 (en) 2006-06-06
EP0779896B1 (en) 2001-10-31
JP4354980B2 (ja) 2009-10-28
DK0779896T3 (da) 2002-02-18
EP0779896A1 (en) 1997-06-25
NZ290374A (en) 1998-07-28
CA2194578A1 (en) 1996-02-08
PT779896E (pt) 2002-03-28
AU699879B2 (en) 1998-12-17
DE69523611T2 (de) 2002-06-20
FI970258A0 (fi) 1997-01-22
WO1996003433A1 (en) 1996-02-08
NO970326L (no) 1997-01-24
AU3109695A (en) 1996-02-22
ATE207934T1 (de) 2001-11-15
FI970258L (fi) 1997-01-22
NO970326D0 (no) 1997-01-24
FI118385B (fi) 2007-10-31
IL114702A0 (en) 1995-11-27
JP2007082554A (ja) 2007-04-05
ZA956139B (en) 1996-03-07
KR100394532B1 (ko) 2003-10-22
DE69523611D1 (de) 2001-12-06

Similar Documents

Publication Publication Date Title
IL114702A0 (en) Process for the production of biologically active protein
IL114701A (en) Process for the production of biologically active dimeric transforming growth factor
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
LTIP1652A (en) Protein, biologically active hormone, method for protein production, pharmaceutical preparation
GB9622229D0 (en) Yeast strains
HU895836D0 (en) Process for the preparation of carrier proteins
CA2213322A1 (en) Thiols to promote hematopoietic progenitor cell growth
EP0374044A3 (en) Tgf - beta 1 / beta 2 : a novel chimeric transforming growth factor-beta.
SI0785950T1 (en) Keratinocyte growth factor analogs
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
DE59610251D1 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
MX9700657A (es) Nuevo proceso para la produccion de proteina biologicamente activa.
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
MX9700656A (es) Proceso novedoso para la produccion de proteina dimerica biologicamente activa.
ZA966371B (en) The preparation of active peptides.
IL145403A0 (en) Fragments of virus protein 2 or 3 of the polyoma virus, use for transporting active ingredients
AU5024490A (en) Method of recovering purified epi protein from a solution especially a fermentation solution
EP0281089A3 (en) Process for the preparation of factor viii:c deficient plasma, and deficient plasma obtained therwith
WO1997041207A3 (en) Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector
ES2004734A6 (es) Procedimiento de obtencion de conjugados biologicamente activos de metaloproteina-albumina o metaloproteina-albumina-anticuerpos
GB9613638D0 (en) Protein gene product 9.5 purified to homogeneity, process for its preparation and use

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees